Bromocriptine Response in Pathological Hyperprolactinemia: A 34 Year Follow-Up of a Homogeneous Population of 827 Patients

Abstract

patients with symptomatic pathological hyperprolactinemia were treated with bromocriptine. The evaluation, treatment, and follow-up was by a single individual, making this a large and unique homogeneous group for purposes of treatment evaluation.